FDA Tells Stem Cell Cos. Regulatory Eyes Fixed On Them

By Alison Noon · December 20, 2018, 9:28 PM EST

The U.S. Food and Drug Administration on Thursday said it has sent a warning letter to Genetech Inc. for marketing "dangerous unapproved stem cell products," as well as to other clinics...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Recent Articles By Alison

April 30, 2019
With Opioid Charges, DOJ Signals Compliance Fixation
April 11, 2019
Trump Admin Moves To Rein In Agency Guidance Materials
March 22, 2019
Medtronic Warning Highlights Debate On FDA Cyber Policy
January 16, 2019
Outcome Health Adds Compliance Chief After Fraud Claims
October 05, 2018
Tobacco Warning Labels Ready By 2021 At Earliest, FDA Says
October 02, 2018
Ex-Abbott Researcher Says 'Erroneous' Law Sank FCA Claims
September 20, 2018
2nd Circuit Balks At Bid To Lower No-Fault Fraud Sentence
September 19, 2018
Mass. Doc Dodges Prison After Giving Patient Info To Drug Co.
September 18, 2018
Mass. Hospital Rips FCA Claims Med Students Not Supervised
September 05, 2018
FDA Ordered To Finish Overdue Graphics For Tobacco Labels